SFSIG
ARNA

San Francisco Sentry Investment Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

San Francisco Sentry Investment Group’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-120
Closed -$8K – 674
2014
Q1 		$8K Buy
+120
New +$7.96K ﹤0.01% 556

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

San Francisco Sentry Investment Group's ARNA Position: Q2 2014 in Review

San Francisco Sentry Investment Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2014, closing a stake of 120 shares — an estimated $8K sold.

San Francisco Sentry Investment Group first reported a position in ARNA in Q1 2014 and held it in 1 quarter. The position peaked at $8K in Q1 2014. 129 funds tracked by Wall St. Rank hold ARNA as of Q2 2014.

  • San Francisco Sentry Investment Group reported no remaining Arena Pharmaceuticals Inc position as of Q2 2014 after selling out during the quarter.
  • San Francisco Sentry Investment Group sold 120 Arena Pharmaceuticals Inc shares in Q2 2014, an estimated $8K.
  • San Francisco Sentry Investment Group first reported a position in Arena Pharmaceuticals Inc in Q1 2014 and held it in 1 quarter.
  • San Francisco Sentry Investment Group's Arena Pharmaceuticals Inc position peaked at $8K in Q1 2014.
  • 129 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2014.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2014, filed 18 Jul 2014.